Industry Resources | November 16, 2018
Telemedicine & Prescribing Buprenorphine For The Treatment Of Opioid Use Disorder
This document was released in September 2018 by the federal Department of Health and Human Services (HHS). In the document, HHS encourages the use of telemedicine to increase access to medication assisted treatment (MAT) for opioid use disorder. HHS is working with the Drug Enforcement Administration (DEA) to clarify how provider organizations and professionals with a DEA waiver under the Drug Addiction Treatment Act of 2000 (DATA 2000) to prescribe buprenorphine can use telemedicine as a tool to expand buprenorphine treatment for opioid use disorder under current DEA regulations . . .